Blue Cross Blue Shield to Pay $2.6B in Class-Action Settlement

Payments to begin in May 2026 for those who filed claims by November 2021 deadline

Published on Feb. 23, 2026

Blue Cross Blue Shield has agreed to pay $2.67 billion to individuals and businesses as part of a class-action antitrust lawsuit settlement reached nearly six years ago. The initial distribution of payments to those with valid claims is scheduled to begin in May 2026, with around $1.78 billion going toward individuals, insured groups, and their employees, and a separate $120 million fund created for self-funded accounts and their employees.

Why it matters

This settlement is a significant payout resulting from allegations that Blue Cross Blue Shield violated antitrust laws by limiting competition among its individual health plans. The case highlights ongoing scrutiny of consolidation and anti-competitive practices in the health insurance industry, which can impact consumer choice and pricing.

The details

Blue Cross Blue Shield denied any allegations of wrongdoing but agreed to the $2.67 billion settlement in 2020 to resolve the class-action lawsuit. To receive a payment, individuals and businesses had to file a claim by November 5, 2021. Around $1.78 billion of the fund will go toward individuals, insured groups, and their employees, while a separate $120 million fund was created for self-funded accounts and their employees.

  • The class-action lawsuit was fought nearly six years ago.
  • Blue Cross Blue Shield agreed to the $2.67 billion settlement in 2020.
  • The claim filing deadline was November 5, 2021.
  • The initial distribution of payments is scheduled to begin in May 2026.

The players

Blue Cross Blue Shield

A major health insurance provider that agreed to pay $2.67 billion to settle an antitrust lawsuit.

Got photos? Submit your photos here. ›

What’s next

The initial distribution of payments to those with valid claims is scheduled to begin in May 2026.

The takeaway

This settlement highlights ongoing scrutiny of consolidation and anti-competitive practices in the health insurance industry, which can impact consumer choice and pricing. The payout demonstrates the potential consequences for companies found to be in violation of antitrust laws.